PARIS & NOTTINGHAM, England--(BUSINESS WIRE)--Iktos, a company specialized in Artificial Intelligence (AI) for new drug design and Sygnature Discovery, a leading integrated drug discovery CRO ...

CAMBRIDGE, England--(BUSINESS WIRE)--DeepMirror, a University of Cambridge spin-out company developing intuitive design software for the discovery of novel therapeutic drugs, today announced the ...

If a picture is worth 1,000 words, a 3D model of a new drug candidate is worth far more. After all, such a model can help the drug candidate’s designers make sense of their voluminous data—which ...

Intellicule has received a $217,941 NIH SBIR Phase I grant to develop advanced deep-learning software for biomolecular modelling ...

In 2020 Collaborations Pharmaceuticals, a company that specializes in looking for new drug candidates for rare and communicable diseases, received an unusual request. The private Raleigh, N.C., firm ...

Artificial intelligence (AI)-based drug developer Isomorphic Labs said it has raised $600 million in its first external funding round, with the proceeds expected to accelerate its research and ...

Iktos, a company specialized in Artificial Intelligence (AI) for new drug design and Sygnature Discovery, a leading integrated drug discovery CRO headquartered in Nottingham, UK, with expertise across ...